首页> 外文期刊>Scandinavian journal of clinical and laboratory investigation. >Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.
【24h】

Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests.

机译:去除了部分纯化的人血浆激肽释放酶以及剩余的IgG部分-免疫印迹实验和功能测试。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study it is shown that a preparation of highly purified plasma kallikrein (specific activity 81 S-2302 U/mg) still contained small amounts of an IgG fraction. Amidase assays of the fresh enzyme with four peptide substrates (S-2302, Bz-Pro-Phe-Arg-pNA, S-2366, S-2222) did not reveal any inhomogeneity, and immunoblot experiments with antibodies against prekallikrein yielded only an 85 kD double band. After a storage period (2 years at -70 degrees C), S-2366 and S-2222 amidase activities not reflecting the initial kallikrein appeared. Immunoblot studies with Fc-specific antibodies against IgG showed a 170 kD band, and immunoblots with a monoclonal antibody against prekallikrein demonstrated that, in addition to the 85 kD band, a band with a mol weight of about 152 kD could also be detected. Immunoblots showed that only 85 kD kallikrein was recovered in the eluate from Protein G columns, and amidase assays based on S-2302 and Bz-Pro-Phe-Arg-pNA showed a recovery of about 70%. The other part of the kallikrein (30%) was removed along with the additional S-2366 and S-2222 activities and the IgG3 fraction present. The theory is advanced that the additional activity reflects a kallikrein fraction with a mol weight of about 152 kD, and is present in the fresh enzyme preparation in inactive complex with IgG. Storage of the kallikrein preparation led to some weakening of this complex and the appearance of functional activities of the kallikrein fraction involved.
机译:在本研究中显示,高纯度血浆激肽释放酶的制剂(比活性为81 S-2302 U / mg)仍包含少量IgG馏分。具有四个肽底物(S-2302,Bz-Pro-Phe-Arg-pNA,S-2366,S-2222)的新鲜酶的酰胺酶测定未显示任何不均一性,抗前激肽释放酶抗体的免疫印迹实验仅产生85 kD双频。储存期(在-70摄氏度下保存2年)后,出现了S-2366和S-2222酰胺酶活性,这些活性不能反映最初的激肽释放酶。使用针对IgG的Fc特异性抗体的免疫印迹研究显示170 kD谱带,针对抗激肽释放酶原的单克隆抗体的免疫印迹表明,除了85 kD谱带外,还可以检测到摩尔分子量约为152 kD的谱带。免疫印迹表明,从Protein G色谱柱的洗脱液中仅回收了85 kD激肽释放酶,基于S-2302和Bz-Pro-Phe-Arg-pNA的酰胺酶测定表明回收率约为70%。激肽释放酶的另一部分(30%)与其他S-2366和S-2222活性以及存在的IgG3部分一起被去除。提出的理论是,额外的活性反映了激肽释放酶组分,其分子量约为152 kD,并以与IgG失活的复合物形式存在于新鲜酶制剂中。激肽释放酶制剂的储存导致该复合物的一些减弱和所涉及的激肽释放酶级分的功能活性的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号